YOMOGI

This brand name is authorized in Austria, Germany

Active ingredients

The drug YOMOGI contains one active pharmaceutical ingredient (API):

1 Yeast
UNII 978D8U419H - SACCHAROMYCES CEREVISIAE

Saccharomyces boulardii is an intestinal flora replacement which acts as antidiarrheal microorganisms in the digestive tract. During transit under its viable form in the digestive tract, saccharomyces boulardii exerts biological actions which are similar to the protective properties of the normal intestinal flora.

Read about Saccharomyces boulardii

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A07FA02 Saccharomyces boulardii A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07F Antidiarrheal microorganisms → A07FA Antidiarrheal microorganisms
Discover more medicines within A07FA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: DE Bundesinstitut fĂźr Arzneimittel und Medizinprodukte Identifier(s): 01499119, 01499131, 01499148, 11885912, 11885929, 11885935

Š All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈